-
Something wrong with this record ?
Time- and dose-dependent seeding tendency of exogenous tau R2 and R3 aggregates in cells
N. Annadurai, J. Hrubý, A. Kubíčková, L. Malina, M. Hajdúch, V. Das
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Alzheimer Disease * pathology MeSH
- HEK293 Cells MeSH
- Humans MeSH
- Protein Isoforms metabolism MeSH
- tau Proteins metabolism MeSH
- Tauopathies * pathology MeSH
- Protein Binding MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Tauopathies are a group of neurodegenerative diseases categorised into three types, 3R, 4R, or 3R+4R (mixed) tauopathies, based on the tau isoforms that make up the aberrant filaments. It is supposed that all six tau isoforms share functional characteristics. However, differences in the neuropathological features associated with different tauopathies offer the possibility that disease progression and tau accumulation may vary depending on the isoform composition. The presence or absence of repeat 2 (R2) in the microtubule-binding domain defines the type of isoform, which might influence tau pathology associated with a particular tau isoform. Therefore, our study aimed to identify the differences in the seeding propensities of R2 and repeat 3 (R3) aggregates using HEK293T biosensor cells. We show that the seeding induced by R2 was generally higher than by R3 aggregates, and lower concentrations of R2 aggregates are sufficient to induce seeding. Next, we found that both R2 and R3 aggregates dose-dependently increased triton-insoluble Ser262 phosphorylation of native tau, which is only visible in cells seeded with higher concentrations (12.5 nM or 100 nM) of R2 and R3 aggregates, despite the seeding by the lower concentrations of R2 aggregates after 72 h. However, the accumulation of triton-insoluble pSer262 tau was visible earlier in cells induced with R2 than in R3 aggregates. Our findings suggest that the R2 region may contribute to the early and enhanced induction of tau aggregation and define the difference in disease progression and neuropathology of 4R tauopathies.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003617
- 003
- CZ-PrNML
- 005
- 20230425140748.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbrc.2023.02.057 $2 doi
- 035 __
- $a (PubMed)36863211
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Annadurai, Narendran $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900, Olomouc, Czech Republic
- 245 10
- $a Time- and dose-dependent seeding tendency of exogenous tau R2 and R3 aggregates in cells / $c N. Annadurai, J. Hrubý, A. Kubíčková, L. Malina, M. Hajdúch, V. Das
- 520 9_
- $a Tauopathies are a group of neurodegenerative diseases categorised into three types, 3R, 4R, or 3R+4R (mixed) tauopathies, based on the tau isoforms that make up the aberrant filaments. It is supposed that all six tau isoforms share functional characteristics. However, differences in the neuropathological features associated with different tauopathies offer the possibility that disease progression and tau accumulation may vary depending on the isoform composition. The presence or absence of repeat 2 (R2) in the microtubule-binding domain defines the type of isoform, which might influence tau pathology associated with a particular tau isoform. Therefore, our study aimed to identify the differences in the seeding propensities of R2 and repeat 3 (R3) aggregates using HEK293T biosensor cells. We show that the seeding induced by R2 was generally higher than by R3 aggregates, and lower concentrations of R2 aggregates are sufficient to induce seeding. Next, we found that both R2 and R3 aggregates dose-dependently increased triton-insoluble Ser262 phosphorylation of native tau, which is only visible in cells seeded with higher concentrations (12.5 nM or 100 nM) of R2 and R3 aggregates, despite the seeding by the lower concentrations of R2 aggregates after 72 h. However, the accumulation of triton-insoluble pSer262 tau was visible earlier in cells induced with R2 than in R3 aggregates. Our findings suggest that the R2 region may contribute to the early and enhanced induction of tau aggregation and define the difference in disease progression and neuropathology of 4R tauopathies.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a proteiny tau $x metabolismus $7 D016875
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 12
- $a tauopatie $x patologie $7 D024801
- 650 _2
- $a protein - isoformy $x metabolismus $7 D020033
- 650 _2
- $a vazba proteinů $7 D011485
- 650 12
- $a Alzheimerova nemoc $x patologie $7 D000544
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hrubý, Jiří $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900, Olomouc, Czech Republic
- 700 1_
- $a Kubíčková, Agáta $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900, Olomouc, Czech Republic
- 700 1_
- $a Malina, Lukáš $u Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900, Olomouc, Czech Republic; Czech Advanced Technologies and Research Institute (CATRIN), Institute of Molecular and Translational Medicine, Palacký University Olomouc, Křížkovského 511/8, 77900, Olomouc, Czech Republic
- 700 1_
- $a Das, Viswanath $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 1333/5, 77900, Olomouc, Czech Republic; Czech Advanced Technologies and Research Institute (CATRIN), Institute of Molecular and Translational Medicine, Palacký University Olomouc, Křížkovského 511/8, 77900, Olomouc, Czech Republic. Electronic address: viswanath.das@upol.cz
- 773 0_
- $w MED00009307 $t Biochemical and biophysical research communications $x 1090-2104 $g Roč. 653, č. - (2023), s. 102-105
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36863211 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140744 $b ABA008
- 999 __
- $a ok $b bmc $g 1924351 $s 1189826
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 653 $c - $d 102-105 $e 20230223 $i 1090-2104 $m Biochemical and biophysical research communications $n Biochem Biophys Res Commun $x MED00009307
- LZP __
- $a Pubmed-20230418